2024/2025
"We value Robin Ellis & team’s superior skills, and experience with biosimilars. They have deep knowledge in the specialized world of biosimilars and generic drug patent litigation. Superior professionalism and service."
Robin Ellis
"Involved in client counselling and problem solving."
2023
"They are a great team to work with."
"They are efficient and effective."
"I have a long history of working with Reddie & Grose and find that the practitioners there are well versed technically, and provide sound business advice for navigating the UK and Europe for my clients."
"My predecessors and I have found the partners to be expert, timely, polite and proficient. Can you ask anything more?"
2022 client testimonials
"They have a long history of excellent work."
"Diligent, competent and available."
"The firm has been very proactive in reaching out and supporting our start-ups. They are clearly passionate about tackling the climate change issues we face and we felt they were a good match as a result."
"They are very personable, with a long history and credibility. They have always been open to taking questions from our start-ups and offering advice."
"Thorough, detailed work. Responsive and timely."
"They have served us successfully for many years."
"Accurate and honest. They are fast, commercially aware, and very easy to deal with."
"They listened and engaged well in conversations. They seemed good value for a small business."
"There was a consistent desire to work with me, enabling me to participate in determining what we should do, and enabling me to give informed instructions. They were pragmatic, knowledgeable and realistic at all times. They were transparent about costs."
In February 2024, the firm announced that two of its long-serving partners, Patrick Lloyd and Simon Goodman, will retire in March 2024. Lloyd was ranked as an IP Star in the 2023 edition.